DK1362590T3 - Anvendelse af cilobradin eller farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt - Google Patents

Anvendelse af cilobradin eller farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt

Info

Publication number: DK1362590T3
Authority: DK; Denmark
Prior art keywords: cilobradine; prevention; treatment; pharmaceutically acceptable; acceptable salts
Prior art date: 2002-07-25

Application number

DK02016602T

Other languages

Danish (da)

English (en)

Inventor

Brian Guth Dr

Randolf Seidler Dr

Juergen Daemmgen Dr

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-25

Filing date

2002-07-25

Publication date

2004-03-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29265956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1362590(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-07-25 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2004-03-29 Application granted granted Critical

2004-03-29 Publication of DK1362590T3 publication Critical patent/DK1362590T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK02016602T 2002-07-25 2002-07-25 Anvendelse af cilobradin eller farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt DK1362590T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02016602A EP1362590B1 (en)	2002-07-25	2002-07-25	Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Publications (1)

Publication Number	Publication Date
DK1362590T3 true DK1362590T3 (da)	2004-03-29

Family

ID=29265956

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK02016602T DK1362590T3 (da)	2002-07-25	2002-07-25	Anvendelse af cilobradin eller farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt
DK03771064.7T DK1534296T3 (da)	2002-07-25	2003-07-21	Anvendelse af cilobradin eller de farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK03771064.7T DK1534296T3 (da)	2002-07-25	2003-07-21	Anvendelse af cilobradin eller de farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt

Country Status (29)

Country	Link
US (1)	US20130317008A1 (sl)
EP (2)	EP1362590B1 (sl)
JP (3)	JP2005533853A (sl)
KR (1)	KR20050074432A (sl)
CN (1)	CN100502874C (sl)
AR (1)	AR040690A1 (sl)
AT (2)	ATE257384T1 (sl)
AU (1)	AU2003254554B8 (sl)
BR (1)	BR0312852A (sl)
CA (1)	CA2493208C (sl)
CO (1)	CO5700723A2 (sl)
CY (1)	CY1112173T1 (sl)
DE (1)	DE60200160T2 (sl)
DK (2)	DK1362590T3 (sl)
ES (2)	ES2211846T3 (sl)
HR (1)	HRP20050075B1 (sl)
MX (1)	MXPA05000617A (sl)
MY (1)	MY128529A (sl)
NZ (1)	NZ538424A (sl)
PE (1)	PE20040706A1 (sl)
PL (1)	PL214716B1 (sl)
PT (2)	PT1362590E (sl)
SA (1)	SA03240350B1 (sl)
SI (2)	SI1362590T1 (sl)
TR (1)	TR200400127T4 (sl)
TW (1)	TWI319321B (sl)
UY (1)	UY27910A1 (sl)
WO (1)	WO2004011006A1 (sl)
ZA (1)	ZA200500084B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2211846T3 (es) *	2002-07-25	2004-07-16	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	Uso de cilobradina o sus sales farmaceuticamente aceptables para el tratamiento o la prevencion de la insuficiencia cardiaca.
US20040138306A1 (en)	2002-07-25	2004-07-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1917979A4 (en) *	2005-08-23	2009-06-03	Astellas Pharma Inc	THERAPEUTICS FOR PREVIOUS LIVING ROOMS
EP1762179A1 (en)	2005-09-07	2007-03-14	Boehringer Ingelheim Vetmedica Gmbh	Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) *	2005-12-21	2010-12-03	Servier Lab	Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2927538B1 (fr)	2008-02-14	2010-02-19	Servier Lab	Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
FR2961105B1 (fr) *	2010-06-15	2013-02-08	Servier Lab	Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
AU2012296925A1 (en) *	2011-08-12	2014-02-06	Boehringer Ingelheim Vetmedica Gmbh	Taste masked pharmaceutical composition
EP2953612A1 (en)	2013-02-11	2015-12-16	Boehringer Ingelheim Vetmedica GmbH	Kit-of-parts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5175157A (en) *	1985-11-27	1992-12-29	Boehringer Ingelheim Gmbh	Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3541811A1 (de) *	1985-11-27	1987-06-04	Thomae Gmbh Dr K	Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3736866A1 (de) *	1987-10-30	1989-05-11	Thomae Gmbh Dr K	Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) *	1988-02-24	1989-09-07	Thomae Gmbh Dr K	Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5760069A (en) *	1995-02-08	1998-06-02	Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1	Method of treatment for decreasing mortality resulting from congestive heart failure
JP4240173B2 (ja) *	1998-06-03	2009-03-18	日産化学工業株式会社	インダン誘導体
ATE262518T1 (de) *	1999-06-03	2004-04-15	Yamanouchi Pharma Co Ltd	Neuartige isoquinolin-derivate oder salze davon
DE10018401A1 (de) *	2000-04-13	2001-10-25	Boehringer Ingelheim Pharma	Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
ES2211846T3 (es) *	2002-07-25	2004-07-16	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	Uso de cilobradina o sus sales farmaceuticamente aceptables para el tratamiento o la prevencion de la insuficiencia cardiaca.

2002
- 2002-07-25 ES ES02016602T patent/ES2211846T3/es not_active Expired - Lifetime
- 2002-07-25 PT PT02016602T patent/PT1362590E/pt unknown
- 2002-07-25 AT AT02016602T patent/ATE257384T1/de active
- 2002-07-25 TR TR2004/00127T patent/TR200400127T4/xx unknown
- 2002-07-25 EP EP02016602A patent/EP1362590B1/en not_active Expired - Lifetime
- 2002-07-25 DE DE60200160T patent/DE60200160T2/de not_active Expired - Lifetime
- 2002-07-25 SI SI200230008T patent/SI1362590T1/sl unknown
- 2002-07-25 DK DK02016602T patent/DK1362590T3/da active
2003
- 2003-07-21 AT AT03771064T patent/ATE510543T1/de active
- 2003-07-21 CN CNB03817829XA patent/CN100502874C/zh not_active Expired - Fee Related
- 2003-07-21 AU AU2003254554A patent/AU2003254554B8/en not_active Ceased
- 2003-07-21 HR HRP20050075AA patent/HRP20050075B1/hr not_active IP Right Cessation
- 2003-07-21 PT PT03771064T patent/PT1534296E/pt unknown
- 2003-07-21 NZ NZ538424A patent/NZ538424A/en not_active IP Right Cessation
- 2003-07-21 BR BR0312852-0A patent/BR0312852A/pt not_active Application Discontinuation
- 2003-07-21 DK DK03771064.7T patent/DK1534296T3/da active
- 2003-07-21 MX MXPA05000617A patent/MXPA05000617A/es active IP Right Grant
- 2003-07-21 EP EP03771064A patent/EP1534296B1/en not_active Expired - Lifetime
- 2003-07-21 CA CA2493208A patent/CA2493208C/en not_active Expired - Fee Related
- 2003-07-21 KR KR1020057001298A patent/KR20050074432A/ko not_active Ceased
- 2003-07-21 PL PL372993A patent/PL214716B1/pl unknown
- 2003-07-21 SI SI200332021T patent/SI1534296T1/sl unknown
- 2003-07-21 WO PCT/EP2003/007929 patent/WO2004011006A1/en not_active Ceased
- 2003-07-21 ES ES03771064T patent/ES2367109T3/es not_active Expired - Lifetime
- 2003-07-21 JP JP2004523757A patent/JP2005533853A/ja active Pending
- 2003-07-23 MY MYPI20032768A patent/MY128529A/en unknown
- 2003-07-24 PE PE2003000735A patent/PE20040706A1/es not_active Application Discontinuation
- 2003-07-24 TW TW092120260A patent/TWI319321B/zh not_active IP Right Cessation
- 2003-07-25 AR AR20030102678A patent/AR040690A1/es not_active Application Discontinuation
- 2003-07-31 UY UY27910A patent/UY27910A1/es not_active Application Discontinuation
- 2003-10-19 SA SA03240350A patent/SA03240350B1/ar unknown
2005
- 2005-01-05 ZA ZA2005/00084A patent/ZA200500084B/en unknown
- 2005-02-24 CO CO05017675A patent/CO5700723A2/es not_active Application Discontinuation
2009
- 2009-08-06 JP JP2009183392A patent/JP2009256379A/ja active Pending
2011
- 2011-08-24 CY CY20111100812T patent/CY1112173T1/el unknown
2013
- 2013-05-21 JP JP2013107160A patent/JP2013166781A/ja active Pending
- 2013-08-01 US US13/956,918 patent/US20130317008A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2211846T3 (es)	2004-07-16
HRP20050075B1 (hr)	2013-12-20
DE60200160D1 (de)	2004-02-12
BR0312852A (pt)	2005-04-19
US20130317008A1 (en)	2013-11-28
EP1534296A1 (en)	2005-06-01
EP1534296B1 (en)	2011-05-25
TWI319321B (en)	2010-01-11
CN100502874C (zh)	2009-06-24
AU2003254554B8 (en)	2009-02-26
DK1534296T3 (da)	2011-08-15
PT1534296E (pt)	2011-08-18
SI1362590T1 (sl)	2004-04-30
PL372993A1 (en)	2005-08-08
ZA200500084B (en)	2005-10-26
TW200412974A (en)	2004-08-01
UY27910A1 (es)	2004-02-27
CA2493208C (en)	2011-11-01
WO2004011006A1 (en)	2004-02-05
ATE257384T1 (de)	2004-01-15
TR200400127T4 (tr)	2004-02-23
ATE510543T1 (de)	2011-06-15
NZ538424A (en)	2006-10-27
ES2367109T3 (es)	2011-10-28
AR040690A1 (es)	2005-04-13
CO5700723A2 (es)	2006-11-30
EP1362590B1 (en)	2004-01-07
HRP20050075A2 (en)	2005-12-31
SI1534296T1 (sl)	2011-09-30
CY1112173T1 (el)	2015-12-09
JP2013166781A (ja)	2013-08-29
KR20050074432A (ko)	2005-07-18
PT1362590E (pt)	2004-05-31
MY128529A (en)	2007-02-28
AU2003254554B2 (en)	2009-01-29
DE60200160T2 (de)	2004-11-04
EP1362590A8 (en)	2004-02-25
SA03240350B1 (ar)	2007-10-29
JP2009256379A (ja)	2009-11-05
CA2493208A1 (en)	2004-02-05
PE20040706A1 (es)	2004-12-06
JP2005533853A (ja)	2005-11-10
AU2003254554A1 (en)	2004-02-16
EP1362590A1 (en)	2003-11-19
MXPA05000617A (es)	2005-08-19
CN1671392A (zh)	2005-09-21
PL214716B1 (pl)	2013-09-30

Publication	Publication Date	Title
DK1830843T3 (da)	2013-02-11	Indolidon-derivater til behandling eller forebyggelse af fibrotiske sygdomme
DK1803718T3 (da)	2008-10-27	4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
NO20052626D0 (no)	2005-05-31	Middel for forhindring eller behandling av neuropati
DK1446122T5 (da)	2006-08-14	Anvendelse af flibanserin til behandling af uregelmæssigheder ved könsdriften
HUS1500048I1 (hu)	2017-10-30	Ivermectin helyi kiszerelése dermatológiai állapotok kezelésére
DK1522314T3 (da)	2014-05-26	Midler for sygdomme forårsaget af vaskulær sammentrækning eller udvidelse
DK2311818T3 (da)	2013-05-06	Kombination af en 5-phenylthiazolforbindelse som PI3-kinasehæmmer med et antiinflammatorisk, bronchodilatorisk eller antihistaminisk medikament
NO20034590L (no)	2003-12-12	Fremgangsmåter for behandling av vaskul¶r sykdom
DK1354597T3 (da)	2005-12-19	Farmaceutisk kombination til behandling af vævsskader forårsaget af en arterieirrigationsdefekt
NO20050569D0 (no)	2005-02-02	Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
DK1491212T3 (da)	2012-10-29	Middel til behandling af søvnforstyrrelser
NO20045554L (no)	2004-12-20	Fremgangsmate for behandling av diabetes
DK1614419T3 (da)	2012-11-19	Midler til forebyggelse/behandling af retinale nervesygdomme, indeholdende alkyletherderivater eller salte deraf
DK1362590T3 (da)	2004-03-29	Anvendelse af cilobradin eller farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt
DK1173179T3 (da)	2003-07-14	Anvendelse af saredutant og de farmaceutisk acceptable salte heraf til behandling eller forebyggelse af svær depressiv forstyrrelse
DE60326734D1 (de)	2009-04-30	Ligations-behandlungsgerät
NO20040497L (no)	2004-04-14	Amidinderivater for behandling av amyloidose
DK1309322T3 (da)	2006-10-23	Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20054034D0 (no)	2005-08-30	Fremgangsmate for behandling av hypotyroidisme.
DK1140090T3 (da)	2005-04-18	Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt
DK1157987T3 (da)	2003-11-24	S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser
DK1446131T3 (da)	2007-09-10	Anvendelse af specifik dosis af fondaparinux-natrium til behandling af ACS
ITMI20020227A0 (it)	2002-02-07	Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
DK1474415T3 (da)	2011-11-21	1-phenyl-2-heteroaryl-substituerede benzimidazolderivater, deres anvendelse til fremstilling af lægemidler til behandling af immunologiske sygdomme
DK1408977T3 (da)	2005-08-01	Kombinationsterapi for behandling af hjerteinsuffciens